JP2005512998A5 - - Google Patents

Download PDF

Info

Publication number
JP2005512998A5
JP2005512998A5 JP2003541837A JP2003541837A JP2005512998A5 JP 2005512998 A5 JP2005512998 A5 JP 2005512998A5 JP 2003541837 A JP2003541837 A JP 2003541837A JP 2003541837 A JP2003541837 A JP 2003541837A JP 2005512998 A5 JP2005512998 A5 JP 2005512998A5
Authority
JP
Japan
Prior art keywords
hydrogen
lower alkyl
substituted
aminoquinoline
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003541837A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005512998A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/036309 external-priority patent/WO2003039546A1/en
Publication of JP2005512998A publication Critical patent/JP2005512998A/ja
Publication of JP2005512998A5 publication Critical patent/JP2005512998A5/ja
Pending legal-status Critical Current

Links

JP2003541837A 2001-11-09 2002-11-12 抗マラリア治療剤に対する新規の使用 Pending JP2005512998A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34587201P 2001-11-09 2001-11-09
PCT/US2002/036309 WO2003039546A1 (en) 2001-11-09 2002-11-12 New uses for anti-malarial therapeutic agents

Publications (2)

Publication Number Publication Date
JP2005512998A JP2005512998A (ja) 2005-05-12
JP2005512998A5 true JP2005512998A5 (https=) 2006-02-23

Family

ID=23356861

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003541837A Pending JP2005512998A (ja) 2001-11-09 2002-11-12 抗マラリア治療剤に対する新規の使用

Country Status (9)

Country Link
US (1) US20040167162A1 (https=)
EP (1) EP1450803A4 (https=)
JP (1) JP2005512998A (https=)
CN (1) CN1289086C (https=)
AU (1) AU2002363443B2 (https=)
CA (1) CA2466338C (https=)
IL (1) IL161821A0 (https=)
MX (1) MXPA04004393A (https=)
WO (1) WO2003039546A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7084157B2 (en) * 2002-05-17 2006-08-01 Rajeev Raut Ophthalmic pharmaceutical compositions and methods for treating ocular inflammation
BR0318214A (pt) * 2003-03-27 2006-03-21 Council Scient Ind Res análogos de 8-aminoquinolina substituìda no anel, composição anti-malárica, processo para a preparação de análogos de 8-aminoquinolina substituìda no anel, e, uso de análogos de 8-aminoquinolina substituìda no anel
US20070134596A1 (en) * 2005-12-08 2007-06-14 Adrian Lungu Photosensitive printing element having nanoparticles and method for preparing the printing element
RU2008135762A (ru) * 2006-02-16 2010-03-27 Де МакЛин Хоспитал Корпорейшн (US) Способы и композиции для лечения болезни паркинсона
KR101067443B1 (ko) * 2009-06-23 2011-09-27 여오영 하이드록시클로로퀸을 함유하는 치핵 치료를 위한 국소투여용 주사제 조성물
CN103027915A (zh) * 2011-09-29 2013-04-10 中国医学科学院基础医学研究所 氯喹治疗和氯丙嗪预防肺感染和损伤的用途
CN103705516B (zh) * 2013-12-11 2016-01-06 武汉威立得生物医药有限公司 氯喔星在制备治疗或预防流感病毒感染的药物中的应用
KR101828553B1 (ko) * 2016-04-15 2018-02-13 한국화학연구원 신규한 벤조싸이오펜 유도체, 이의 약학적으로 허용 가능한 염 또는 이의 광학 이성질체, 이의 제조방법 및 이를 유효성분으로 함유하는 바이러스성 질환의 예방 또는 치료용 약학적 조성물
CA3029012C (en) * 2016-06-28 2024-10-01 Institut National De La Sante Et De La Recherche Medicale (Inserm) Hycanthone derivatives and primaquine derivatives intended for use in preventing and/or treating conditions associated with Gammaherpesvirinae
CN111658648A (zh) * 2020-02-03 2020-09-15 中国人民解放军军事科学院军事医学研究院 4-氨基喹啉类化合物在治疗冠状病毒感染方面的应用
US20210244705A1 (en) * 2020-02-07 2021-08-12 Centre For Digestive Diseases Therapeutic compositions, products of manufacture and methods for ameliorating or preventing coronavirus infection
CN114657149B (zh) * 2020-02-16 2023-10-20 北京化工大学 西拉菌素在制备治疗冠状病毒感染性疾病的药物的用途
US11007187B1 (en) * 2020-03-25 2021-05-18 Therapeutica Borealis Oy Medicine for Covid-19 and treatment
US11278602B2 (en) 2020-03-25 2022-03-22 Therapeutica Borealis Oy Medicine for Covid-19 and treatment
WO2021191496A1 (en) * 2020-03-25 2021-09-30 Therapeutica Borealis Oy Medicine for covid-19 and treatment
US11638722B2 (en) 2020-03-25 2023-05-02 Therapeutica Borealis Oy C/O Avance Attorneys Ltd. Medicine for Covid-19 and treatment
WO2021204717A1 (en) * 2020-04-06 2021-10-14 Oxandia Ltd Aminoquinolines for treating coronavirus infections
EP3892275A1 (en) * 2020-04-08 2021-10-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Aerosolization of hcq or its metabolites for the treatment of lung infections
JP2023521563A (ja) * 2020-04-14 2023-05-25 グラニス ファーマシューティカル インコーポレイテッド ヒドロキシクロロキン及び／又はクロロキンを含む経皮及び／又は局所送達システム
KR20230035518A (ko) * 2020-04-21 2023-03-14 노암 코헨 선천적 면역 반응을 생성하기 위한 퀴닌과 그의 용도
WO2021212183A1 (en) * 2020-04-24 2021-10-28 Centre For Digestive Diseases Pty Limited Products of manufacture and methods for treating, ameliorating or preventing microbial infections
EP4142728B1 (en) * 2020-04-27 2025-01-29 Immunologik GmbH 6'-methoxycinchonan-9-ols for the treatment of coronaviral infections
WO2021217574A1 (en) * 2020-04-30 2021-11-04 Waterstone Pharmaceuticals (Wuhan) Co., Ltd. Treatment or prevention of coronaviridae infection
CA3192574A1 (en) * 2020-09-14 2022-03-17 Florian Alexis CALVINO Pharmaceutical composition comprising hydroxychloroquine and uses thereof
DE102021000717A1 (de) * 2021-02-12 2022-08-18 Forschungszentrum Jülich GmbH Quinacrin als lnhibitor viraler Cysteinproteasen und/oder Serinproteasen
US20240391876A1 (en) * 2021-08-19 2024-11-28 Arizona Board Of Regents On Behalf Of The University Of Arizona Quinacrine and derivatives thereof for treatment of viral infections
CN115869311A (zh) * 2022-12-30 2023-03-31 湖北工业大学 MefloquineHydrochloride在制备抗腺病毒ADV7药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4181725A (en) * 1977-05-02 1980-01-01 The Regents Of The University Of Michigan Method for alleviating psoriasis
US4496549A (en) * 1983-01-17 1985-01-29 American Cyanamid Company Treatment of malaria with antibiotics
US5153202A (en) * 1988-06-30 1992-10-06 Davis Michael H Method of inhibiting the activity of human immuno deficiency virus (HIV) in vivo
US5376359A (en) * 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
US5827681A (en) * 1996-12-20 1998-10-27 University Technology Corporation Rapid detection and drug sensitivity of malaria
JP2002543122A (ja) * 1999-04-30 2002-12-17 エイピーティー ファーマスーティカルズ エルエルスィー 抗マラリア治療剤についての新規使用

Similar Documents

Publication Publication Date Title
JP2005512998A5 (https=)
CA2466338A1 (en) New uses for anti-malarial therapeutic agents
US20250361211A1 (en) Deuterated cftr potentiators
AU2021200970B2 (en) Deuterated derivatives of ivacaftor
US10047053B2 (en) Deuterated CFTR potentiators
US10759721B2 (en) Deuterated CFTR potentiators
US20090312313A1 (en) Compound having tgfbeta inhibitory activity and pharmaceutical composition comprising the same
CA2372443A1 (en) Local administration of anti-malarial agents for the treatment of inflammatory diseases
JP6146990B2 (ja) 重水素化されたｃｆｔｒ増強物質
JP2007008816A (ja) 新規イソキノリン誘導体
US20070155788A1 (en) Quinoline Inhibitors of cGMP Phosphodiesterase
JP2019521092A (ja) ヒストン脱アセチル化酵素６阻害剤およびその使用
Horta et al. Quinolones for Applications in Medicinal Chemistry: Synthesis and Structure
CN109364075B (zh) 氘化cftr增效剂
JP2007511570A5 (https=)
WO2011091035A1 (en) Aminoquinoline derivatives
JP2900130B2 (ja) カルボスチリル誘導体及び該誘導体を含有する精神分裂病治療剤
KR102070361B1 (ko) 중수소화 ｃｆｔｒ 강화제
HK40004908A (en) Deuterated cftr potentiators
HK40004908B (zh) 氘化 cftr 增效剂
HK1244183B (en) Deuterated derivatives of ivacaftor
JP2017105824A (ja) 重水素化されたｃｆｔｒ増強物質
HK1196350B (en) Deuterated derivatives of ivacaftor
HK1196350A (en) Deuterated derivatives of ivacaftor
HK1075619B (en) New uses for anti-malarial therapeutic agents